by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Eurofins SF Analytical Laboratories, Inc. Warning Letter Details

Warning Letter

Eurofins SF Analytical Laboratories, Inc.

Eurofins SF Analytical Laboratories, Inc., 2345 South 170th Street New Berlin , WI 53151 United States, (b)(4)

Issue DateOctober 06, 2026

FEI Number3014704316

Violations4

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Eurofins SF Analytical Laboratories, Inc. FDA Warning Letter, October 6, 2026